| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | 0.38 | 0.01 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.02 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |